New Signatory Onboarding Programme

The qualification gives you the certificate. This gives you the confidence to actually use it.

A structured 3-month programme for newly qualified ABPI Final Medical Signatories. One-to-one with Anzal. Real materials, real cases, real decisions — with someone who has made thousands of them.

3-Month Programme
1:1 with Anzal
Real Case Review
Decision Frameworks

Passing the exam and signing off launch materials are two completely different things

The ABPI qualification tests knowledge of the Code. It does not teach you how to make consistent, defensible decisions under pressure, at pace, with commercial teams pushing in the opposite direction.

Certificate in hand — but no confidence in the grey areas

The exam rewards knowledge of the Code's structure. Actual sign-off work is 80% grey areas where the Code is silent, precedent matters, and getting it wrong has consequences. The exam doesn't prepare you for that.

Being asked to sign things the moment the ink is dry on the qualification

No ramp-up period. No shadowing a senior signatory. No sense of what a defensible rationale looks like. Just materials arriving in the queue from day one, each one expecting a decision.

No senior signatory to observe or learn from in-house

In many organisations, the new signatory is the only signatory. There is no one to ask when a material is genuinely borderline, no one who can tell you what the previous approach was, and no one calibrating your decisions.

Signing under commercial pressure with no framework to push back

Marketing timelines are tight. Launch dates are fixed. The pressure to approve materials quickly is real and constant. Without a robust rationale framework, it is very difficult to hold a position — or explain clearly why you are holding it.

Seven areas where newly qualified signatories most commonly need depth

The programme is structured around what the qualification exam does not teach — applied judgement, decision frameworks, and calibration against an experienced signatory's reasoning.

1

ABPI Code 2024 in depth — beyond the exam syllabus

The clauses the exam tests you on, and the clauses it doesn't. The interpretive principles that experienced signatories apply when the Code's wording runs out — and how PMCPA case outcomes shape those interpretations.

2

PMCPA case study application

Working through real published PMCPA findings and mapping them to current decision scenarios. Understanding why panels ruled as they did — and what that means for materials you are likely to sign next week.

3

Common signatory errors and how to avoid them

The recurring mistakes new signatories make — over-approval in borderline cases, under-documented rationale, inconsistent application across materials, and failure to apply the high standards test rigorously.

4

How to write defensible rationale

What a sign-off rationale needs to demonstrate, how to articulate the basis for a decision in writing, and what the record needs to show if that decision is ever reviewed by PMCPA or an inspector.

5

Handling pressure from commercial and marketing

Practical frameworks for maintaining a position under timeline and approval pressure — including how to communicate the basis for a rejection clearly, professionally, and without creating unnecessary conflict.

6

Managing volume, prioritisation, and escalation

How to manage a high-volume caseload without decisions degrading under pressure. When to escalate, when to take more time, and when to proceed — and how to document the reasoning either way.

I passed the exam and was immediately signing off launch materials with no one to ask. The onboarding programme gave me frameworks for every type of material and someone to sense-check my thinking against. My confidence in marginal cases went from 3/10 to 8/10 within six weeks.

Newly Qualified Final Signatory — UK Affiliate

The sessions where Anzal reviewed actual materials I'd signed — and explained where my reasoning was strong and where it had gaps — were transformative. Nothing in the qualification prepares you for that level of applied critique.

Medical Signatory — Biotech

Designed for signatories in the first twelve months of their role

Newly qualified signatories

Recently passed the ABPI Final Medical Signatory qualification and now in the role — or about to be appointed.

Signatories with no senior peer to learn from

The only signatory in their organisation — no internal calibration point and no one to escalate borderline decisions to.

Signatories moving from a different therapeutic area

Experienced signatories entering a new therapy area or product type where the promotional landscape and precedent is unfamiliar.

Companies investing in a newly appointed team member

Organisations that have promoted internally or hired a new signatory and want to accelerate their ramp-up with structured external support.

Signatories who are inconsistent under pressure

Qualified and experienced but aware that their decisions in high-pressure or fast-turnaround situations are less confident than they should be.

Individuals arranging their own development

Signatories taking personal responsibility for their professional development — not waiting for their organisation to provide what it often doesn't.

How the programme works

Who is this for?

Newly qualified ABPI signatories, or those moving into a Final Medical Signatory role for the first time — typically within the first 12 months of qualification. The programme also suits experienced signatories entering a new therapy area or working without a senior peer to benchmark against.

What does a typical session look like?

A 60-minute 1:1 — a working combination of case review, live material assessment, and framework building. Between sessions, participants review published PMCPA cases and prepare judgements for discussion. The sessions are applied, not didactic — the aim is to build your decision-making muscle, not to lecture.

How many sessions are included?

Session cadence and total number are discussed on the discovery call and structured to the individual's starting point, caseload, and the pace at which they want to progress. The programme runs over 3 months but is built around your actual working reality, not a fixed template.

Can this be arranged for a company with a new in-house signatory?

Yes — the programme works both for individuals arranging it privately and for companies investing in a newly appointed team member. Where a company is funding the programme, the structure can include check-in points for the medical director or line manager if that is useful.

The qualification is the start. The programme is where real confidence comes from.

Book a discovery call to discuss your current situation, caseload, and how the programme would be structured around your role. No commitment required at this stage.

Book a Discovery Call

Need instant answers?

19 specialist AI advisors — available 24/7

ABPI Code compliance, pharmacovigilance, GVP modules, signal detection and more. Ask anything, get structured referenced answers in seconds. From £9/month.

Explore AI Advisors → Try free →

Free Resource

📄 Free Download: The New Final Signatory Survival Guide

Everything you need to know in your first 90 days as a UK pharma Final Signatory — your legal responsibilities, the 7 Code sections to know cold, a 15-point sign-off checklist, and a 90-day action plan.

  • ✓  Instant access — no waiting
  • ✓  Printable PDF format
  • ✓  Written by a UK pharma compliance expert

Enter your details to get instant access:

Download: New Final Signatory Survival Guide
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training